The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)Marc A. Judson, Robert P. Baughman, Dominique Valeyre et al.|Respiratory Medicine|2022Cited by 4
Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis.Rebecca Klein, Robert P. Baughman, Marc A. Judson et al.|PubMed|2023Cited by 3
Low Prevalence of Cardiac Sarcoidosis Using Routine and Enhanced Screening Strategies in Unselected Sarcoidosis Patients: Preliminary Baseline Data from the Foundation for Sarcoidosis Research Clinical Studies Network Screening TrialD.A. Culver, Lisa Maier, T. Shivas et al.|Unknown|2022Cited by 0
Employing a Collaborative Clinical Studies Network Approach to Ascertain Routine Cardiac Screening Practices for Sarcoidosis Patients Across Care Centers InternationallyT. Legenzoff, Daniel A. Culver, Muhunthan Thillai et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0